Radovan Malý/X
Aug 4, 2026, 02:15
Radovan Malý: Finding the Optimal Aspirin Dose in Acute Coronary Syndrome
Radovan Malý, Head of Department at Charles Univeristy in Prague, shared a post on X about a recent article by John W. Eikelboom et al., published in Thrombosis Research, adding:
“Aspirin dose, urinary thromboxane and prostacyclin metabolites, and clinical outcome in acute coronary syndrome:
A nested case-control study from CURRENT-OASIS 7 – Thrombosis Research”
Title: Aspirin dose, urinary thromboxane and prostacyclin metabolites, and clinical outcome in acute coronary syndrome: A nested case-control study from CURRENT-OASIS 7
Authors: John W. Eikelboom, Shamir R. Mehta, Qilong Yi, Jeffrey I. Weitz
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 4, 2026, 03:13William Aird: Understanding von Willebrand Disease – A Visual Roadmap
-
Aug 4, 2026, 02:16New Report Identifies Key Research Priorities for Venous Thrombosis and Stroke – International Journal of Stroke
-
Aug 4, 2026, 02:14Umair Ahmad: Aspirin for Relief Protection and Prevention
-
Aug 4, 2026, 02:12Heavy Menstrual Bleeding in Adolescents Should Never Be Dismissed as “Just a Normal Period” – ICHCC
-
Aug 4, 2026, 02:12Pablo Corral: Viewing Lp(a) as a Multidimensional Particle
-
Aug 3, 2026, 16:01Your First Steps After an ITP Diagnosis – ITP Support Association
-
Aug 3, 2026, 15:33Christina Crossette-Thambiah: Scientific Excellence and Mentorship at ISTH 2026
-
Aug 3, 2026, 15:22Connie Montgomery: Why Global Support is Essential for the HFA Black Voices Initiative
-
Aug 3, 2026, 15:18Ifeanyichukwu Ifechidere: The DOAC Monitoring Masterclass